Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix

Abstract

The aim of the study was to evaluate VEGF expression in tumour biopsies as a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix. A retrospective study was carried out on 100 patients. Pre-treatment tumour VEGF expression was examined immunohistochemically in formalin-fixed, paraffin-embedded biopsies using a widely available commercial antibody. A semi-quantitative analysis was made using a scoring system of 0, 1, 2, and 3, for increasing intensity of staining. High VEGF expression was associated with a poor prognosis. A univariate log rank analysis found a significant relationship with overall survival (P = 0.0008) and metastasis-free survival (P = 0.0062), but not local control (P = 0.23). There was no correlation between VEGF expression and disease stage, tumour differentiation, patient age, or tumour radiosensitivity (SF2). In a Cox multivariate analysis of survival VEGF expression was the most significant independent prognostic factor (P = 0.001). After allowing for VEGF only SF2 was a significant prognostic factor (P = 0.003). In conclusion, immunohistochemical analysis of VEGF expression is a highly significant and independent prognostic indicator of overall and metastasis-free survival for patients treated with radiotherapy for advanced carcinoma of the cervix. It is also a rapid and easy method that could be used in the clinical setting, to identify patients at high risk of failure with conventional radiotherapy who may benefit from novel approaches or chemoradiotherapy.

References 37

1. 1.

   Boocock C. A., Charnock-Jones D. S., Sharkey A. M., McLaren J., Barker P. J., Wright K. A., Twentyman P. R., Smith S. K. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst. 1995;87(7):506-516.

   Not in our library10.1093/jnci/87.7.506

2. 2.

   Bouvet M., Ellis L. M., Nishizaki M., Fujiwara T., Liu W., Bucana C. D., Fang B., Lee J. J., Roth J. A. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res. 1998;58(11):2288-2292.

   Not in our library

3. 3.

   Chiarotto J. A., Hill R. P. A quantitative analysis of the reduction in oxygen levels required to induce up-regulation of vascular endothelial growth factor (VEGF) mRNA in cervical cancer cell lines. Br J Cancer. 1999;80(10):1518-1524.

   Not in our library10.1038/sj.bjc.6690555

4. 4.

   Ferrara N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat. 1995;36(2):127-137.

   Not in our library10.1007/bf00666035

5. 5.

   Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 1990;82(1):4-6.

   Not in our library10.1093/jnci/82.1.4

6. 6.

   Fontanini G., Boldrini L., Chinè S., Pisaturo F., Basolo F., Calcinai A., Lucchi M., Mussi A., Angeletti C. A., Bevilacqua G. Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas. Br J Cancer. 1999;79(2):363-369.

   Not in our library10.1038/sj.bjc.6690058

7. 7.

   Guidi A. J., Abu-Jawdeh G., Berse B., Jackman R. W., Tognazzi K., Dvorak H. F., Brown L. F. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst. 1995;87(16):1237-1245.

   Not in our library10.1093/jnci/87.16.1237

8. 8.

   Hawighorst H., Weikel W., Knapstein P. G., Knopp M. V., Zuna I., Schönberg S. O., Vaupel P., van Kaick G. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res. 1998;4(10):2305-2312.

   Not in our library

9. 9.

   Inoue K., Ozeki Y., Suganuma T., Sugiura Y., Tanaka S. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer. 1997;79(2):206-213.

   Not in our library10.1002/(sici)1097-0142(19970115)79:2<206::aid-cncr2>3.0.co;2-i

10. 10.
    Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer · 1998

    No notice
11. 11.

    Itakura J., Ishiwata T., Friess H., Fujii H., Matsumoto Y., Büchler M. W., Korc M. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin Cancer Res. 1997;3(8):1309-1316.

    Not in our library

12. 12.

    Keys H. M., Bundy B. N., Stehman F. B., Muderspach L. I., Chafe W. E., Suggs C. L., Walker J. L., Gersell D. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340(15):1154-1161.

    Not in our library10.1056/nejm199904153401503

13. 13.

    Kieser A., Weich H. A., Brandner G., Marmé D., Kolch W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene. 1994;9(3):963-969.

    Not in our library

14. 14.

    Kuhnen C., Lehnhardt M., Tolnay E., Muehlberger T., Vogt P. M., Müller K. M. Patterns of expression and secretion of vascular endothelial growth factor in malignant soft-tissue tumours. J Cancer Res Clin Oncol. 2000;126(4):219-225.

    Not in our library10.1007/s004320050036

15. 15.

    Lee Y. H., Tokunaga T., Oshika Y., Suto R., Yanagisawa K., Tomisawa M., Fukuda H., Nakano H., Abe S., Tateishi A. Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Eur J Cancer. 1999;35(7):1089-1093.

    Not in our library10.1016/s0959-8049(99)00073-8

16. 16.

    Linderholm B., Tavelin B., Grankvist K., Henriksson R. Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. J Clin Oncol. 1998;16(9):3121-3128.

    Not in our library10.1200/jco.1998.16.9.3121

17. 17.

    Maeda K., Chung Y. S., Ogawa Y., Takatsuka S., Kang S. M., Ogawa M., Sawada T., Sowa M. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer. 1996;77(5):858-863.

    Not in our library10.1002/(sici)1097-0142(19960301)77:5<858::aid-cncr8>3.0.co;2-a

18. 18.

    Millauer B., Shawver L. K., Plate K. H., Risau W., Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature. 1994;367(6463):576-579.

    Not in our library10.1038/367576a0

19. 19.

    Morris M., Eifel P. J., Lu J., Grigsby P. W., Levenback C., Stevens R. E., Rotman M., Gershenson D. M., Mutch D. G. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340(15):1137-1143.

    Not in our library10.1056/nejm199904153401501

20. 20.

    Nagy J. A., Masse E. M., Herzberg K. T., Meyers M. S., Yeo K. T., Yeo T. K., Sioussat T. M., Dvorak H. F. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res. 1995;55(2):360-368.

    Not in our library

21. 21.

    Obermair A., Bancher-Todesca D., Bilgi S., Kaider A., Kohlberger P., Müllauer-Ertl S., Leodolter S., Gitsch G. Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia. J Natl Cancer Inst. 1997;89(16):1212-1217.

    Not in our library10.1093/jnci/89.16.1212

22. 22.

    Ohta Y., Endo Y., Tanaka M., Shimizu J., Oda M., Hayashi Y., Watanabe Y., Sasaki T. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin Cancer Res. 1996;2(8):1411-1416.

    Not in our library

23. 23.

    Paley P. J., Staskus K. A., Gebhard K., Mohanraj D., Twiggs L. B., Carson L. F., Ramakrishnan S. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer. 1997;80(1):98-106.

    Not in our library10.1002/(sici)1097-0142(19970701)80:1<98::aid-cncr13>3.0.co;2-a

24. 24.

    Parliament M. B., Allalunis-Turner M. J., Franko A. J., Olive P. L., Mandyam R., Santos C., Wolokoff B. Vascular endothelial growth factor expression is independent of hypoxia in human malignant glioma spheroids and tumours. Br J Cancer. 2000;82(3):635-641.

    Not in our library10.1054/bjoc.1999.0975

25. 25.

    Pepper M. S., Ferrara N., Orci L., Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun. 1991;181(2):902-906.

    Not in our library10.1016/0006-291x(91)91276-i

26. 26.

    Presta L. G., Chen H., O'Connor S. J., Chisholm V., Meng Y. G., Krummen L., Winkler M., Ferrara N. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res. 1997;57(20):4593-4599.

    Not in our library

27. 27.

    Rak J., Filmus J., Kerbel R. S. Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis. Eur J Cancer. 1996;32A(14):2438-2450.

    Not in our library10.1016/s0959-8049(96)00396-6

28. 28.

    Rak J., Mitsuhashi Y., Bayko L., Filmus J., Shirasawa S., Sasazuki T., Kerbel R. S. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res. 1995;55(20):4575-4580.

    Not in our library

29. 29.

    Raleigh J. A., Calkins-Adams D. P., Rinker L. H., Ballenger C. A., Weissler M. C., Fowler W. C., Novotny D. B., Varia M. A. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res. 1998;58(17):3765-3768.

    Not in our library

30. 30.

    Senger D. R., Galli S. J., Dvorak A. M., Perruzzi C. A., Harvey V. S., Dvorak H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983;219(4587):983-985.

    Not in our library10.1126/science.6823562

31. 31.

    Takahashi Y., Cleary K. R., Mai M., Kitadai Y., Bucana C. D., Ellis L. M. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res. 1996;2(10):1679-1684.

    Not in our library

32. 32.

    Uchida S., Shimada Y., Watanabe G., Tanaka H., Shibagaki I., Miyahara T., Ishigami S., Imamura M. In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis. Br J Cancer. 1998;77(10):1704-1709.

    Not in our library10.1038/bjc.1998.281

33. 33.

    Vaccine compromise. Nature. 1993;362(6421):576-576.

    Not in our library10.1038/362576a0

34. 34.

    Warren R. S., Yuan H., Matli M. R., Gillett N. A., Ferrara N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest. 1995;95(4):1789-1797.

    Not in our library10.1172/jci117857

35. 35.
    Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix · 1993

    No notice
36. 36.

    Whitney C. W., Sause W., Bundy B. N., Malfetano J. H., Hannigan E. V., Fowler W. C., Clarke-Pearson D. L., Liao S. Y. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999;17(5):1339-1348.

    Not in our library10.1200/jco.1999.17.5.1339

37. 37.
    Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels · 1997

    No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.